Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mikosch

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Calcified Tissue International|June 17, 2008
Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustatP Mikosch, M Reed, R Baker, et al.
Acta Medica Austriaca|January 1, 1997
[Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi]H J Gallowitsch, J Fellinger, E Kresnik, et al.
Nuklearmedizin. Nuclear Medicine|December 6, 2008
Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literatureP Mikosch, S Kohlfürst, H J Gallowitsch, et al.
European Journal of Nuclear Medicine|May 15, 1998
Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalitiesH J Gallowitsch, J Sykora, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|September 4, 2008
Bone- and bone marrow scintigraphy in Gaucher disease type 1P Mikosch, F Zitter, H J Gallowitsch, et al.
Acta Medica Austriaca|May 17, 2000
The role of F-18FDG PET in thyroid cancerP Lind, G Kumnig, S Matschnig, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatmentP Mikosch, B Obermayer-Pietsch, R Jost, et al.
Clinical Nuclear Medicine|January 1, 1997
Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancerP Lind, H J Gallowitsch, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?H-J Gallowitsch, P Kraschl, I Igerc, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2002
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancerI Igerc, G Kumnig, M Heinisch, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Calcified Tissue International|June 17, 2008
Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustatP Mikosch, M Reed, R Baker, et al.
Acta Medica Austriaca|January 1, 1997
[Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi]H J Gallowitsch, J Fellinger, E Kresnik, et al.
Nuklearmedizin. Nuclear Medicine|December 6, 2008
Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literatureP Mikosch, S Kohlfürst, H J Gallowitsch, et al.
European Journal of Nuclear Medicine|May 15, 1998
Attenuation-corrected thallium-201 single-photon emission tomography using a gadolinium-153 moving line source: clinical value and the impact of attenuation correction on the extent and severity of perfusion abnormalitiesH J Gallowitsch, J Sykora, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|September 4, 2008
Bone- and bone marrow scintigraphy in Gaucher disease type 1P Mikosch, F Zitter, H J Gallowitsch, et al.
Acta Medica Austriaca|May 17, 2000
The role of F-18FDG PET in thyroid cancerP Lind, G Kumnig, S Matschnig, et al.
Thyroid : Official Journal of the American Thyroid Association|June 14, 2003
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatmentP Mikosch, B Obermayer-Pietsch, R Jost, et al.
Clinical Nuclear Medicine|January 1, 1997
Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancerP Lind, H J Gallowitsch, P Mikosch, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?H-J Gallowitsch, P Kraschl, I Igerc, et al.
Thyroid : Official Journal of the American Thyroid Association|February 13, 2002
Vocal cord muscle activity as a drawback to FDG-PET in the followup of differentiated thyroid cancerI Igerc, G Kumnig, M Heinisch, et al.
Pageof 7